Will Newton
@WillNewton19
Followers
226
Following
159
Media
1
Statuses
19
Healthcare journalist covering drug pricing policy at 340B Report, Williams College ’20, #MFFL
Brooklyn, NY
Joined August 2020
I spent the last month writing a piece on the future of medicine in outer space! I spoke to researchers about designing drug trials on the ISS, studying how humans respond to cosmic radiation, synthesizing artificial medicine for a Mars mission, and more:.
1
5
13
I asked Dr. Fauci about the challenges of studying long Covid in clinical trial, and heard his takes on Covid misinformation and public perception:.
clinicaltrialsarena.com
Clinical Trials Arena asks Dr Anthony Fauci about the biggest challenges to selecting long Covid-19 trial endpoints during a National Press Foundation Q&A.
0
4
14
After #ASCO22 focused on the need for more diversity in cancer clinical trials, I wrote about how experts are leveraging data to improve trial recruitment and design for @TrialsArena .
0
2
6
RT @TrialsArena: On International Clinical Trials Day, we have a feature on Dengue fever, on the struggle to develop antivirals and vaccine….
0
4
0
Some ultra-rare diseases have fewer than 30 known patients globally and almost no available treatments. I spoke to researchers, regulators and bioethicists on new strategies to test and approve drugs for ultra-rare conditions:.
The FDA defines rare diseases as occurring in less than 200,000 people. But what happens when a disease is so rare it only exists in one person?. @WillNewton19 spoke to researchers and regulators on the challenges of ultra-rare disease drug development.
0
4
8
RT @TrialsArena: NeuroSense CEO @NoonAlon previews an upcoming Phase IIb trial in #ALS with reporter @WillNewton19. Read more about the tar….
clinicaltrialsarena.com
NeuroSense CEO Alon Ben-Noon reveals the target patient population and outcome measures of a planned Phase IIb ALS trial of PrimeC.
0
2
0
I wrote about how e-commerce pharmacies are attempting to cut soaring insulin prices, and the challenges they face, including insulin black markets:.
pharmaceutical-technology.com
An e-commerce drug delivery approach could put a dent in upward spiraling insulin prices, but uptake challenges loom large.
0
2
5
RT @TrialsArena: Differing endpoint and efficacy expectations can make designing an ALS clinical trial challenging. @WillNewton19 talked to….
0
2
0
RT @TrialsArena: In an exclusive, @medicagoinc previews its blueprint for a booster trial of its Covid-19 vaccine candidate slated for Janu….
0
1
0
RT @TrialsArena: Platform trials can streamline rare disease research by testing multiple treatments & diseases under one .protocol. @WillN….
0
2
0
RT @TrialsArena: Clinical Trials Arena's William Newton (@WillNewton19) caught up with @AnnovisBio CEO Maria Maccecchini (@MLMaccecchini).….
0
5
0
RT @TrialsArena: Schizophrenia drug landscape: a stagnant field on the cusp of change? @WillNewton19 talks to experts about Sunovion’s ulot….
0
3
0
RT @ManasiVaidya22: @WillNewton19 and my story on how Merck and Ridgeback’s #molnupiravir rollout will be difficult to map in an uncertain….
0
1
0
Wrote about the incomplete safety data for Aduhelm, the recently FDA-approved Alzheimer’s disease drug
0
0
2
RT @ach_research: .@ArenaClinical – #BioMarin's #vosoritide’s uncertain long-term efficacy may limit European coverage of what could be the….
0
4
0
I wrote about how a rare Medicare process could affect uptake of the controversial Alzheimer's drug Aduhelm .
0
1
4